“Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements”
(OMB Control Number 0910-0785)
Change Request (83-C)
October 13, 2015
The Food and Drug Administration is submitting this nonmaterial/non-substantive change request (83-C) for changes to the pretest and main study questionnaire. These changes include revisions to instructions and questions, and result from cognitive interview findings. There is no change to the burden or data elements.
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| Author | Betts, Kevin |
| File Modified | 0000-00-00 |
| File Created | 2021-01-24 |